2023-02-17 CALL at $5.0 Option on Immunoprecise Antibodies

IPA
 Stock
  

USD 4.68  0.69  17.29%   

2023-02-17 CALL at $5.0 is a CALL option contract on Immunoprecise Antibodies' common stock with a strick price of 5.0 expiring on 2023-02-17. The contract was last traded on 2022-09-23 at 15:44:32 for $0.9 and, as of today, has 137 days remaining before the expiration. The option is currently trading at a bid price of $0.35, and an ask price of $1.25. The implied volatility as of the 3rd of October is 113.2614.
  
Please see Risk vs Return Analysis.
Call options on Immunoprecise Antibodies give the investor right to buy Immunoprecise Stock at a specified price within a specific period. The strike price represents the predetermined price at which a call buyer can buy Immunoprecise Stock. Call options may be purchased for speculation or sold for income purposes, or simply combined for various spread or combination strategies. If Immunoprecise Antibodies' price is above the strike price at expiry, the profit is the current Immunoprecise Antibodies' stock price, minus the strike price and the premium.

Rule 16 of 2023-02-17 Option Contract

The options market is anticipating that Immunoprecise Antibodies will have an average daily up or down price movement of about 7.08% per day over the life of the option. With Immunoprecise Antibodies trading at $4.68, that is roughly $0.33. If you think that the market is fully understating Immunoprecise Antibodies' daily price movement you should consider buying Immunoprecise Antibodies options at that current volatility level of 113.26%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Out Of The Money Call Option on Immunoprecise Antibodies

An 'Out of The Money' option on Immunoprecise has a strike price that Immunoprecise Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for Immunoprecise Antibodies' 'Out of The Money' options include buying the options if you expect a big move in Immunoprecise Antibodies' stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.
Call Contract Name2023-02-17 CALL at $5.0
Expires On2023-02-17
Days Before Expriration137
Last Traded On2022-09-23 15:44:32
Contract PeriodMONTHLY
Open Interest4
Current Trading Volume1.0
Strike Price5.0
Last Traded At0.9
Current Price Spread0.35 | 1.25
Rule 16 Daily Up or Down$0.33

Immunoprecise short CALL Option Greeks

Immunoprecise Antibodies' Option Greeks for the contract ending on 2023-02-17 at a strike price of 5.0 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Immunoprecise Antibodies' option greeks, its implied volatility helps estimate the risk of Immunoprecise Antibodies stock implied by the prices of the options on Immunoprecise Antibodies' stock.
Delta0.5179
Gamma0.1429
Theta-0.0041
Vega0.0098
Rho0.0048

Immunoprecise long CALL Option Payoff at expiration

Buying Immunoprecise Antibodies' call option is the simplest of option trades. A call option on Immunoprecise Stock gives investors the right (but not the obligation) to purchase Immunoprecise Antibodies at the given strike price. Therefore Immunoprecise Antibodies' call intrinsic value or payoff at expiration depends on where the Immunoprecise Stock price is relative to the call option strike price. The strike price of 5.0 is the critical point that divides the payoff function into two parts. Below the strike, the payoff chart is constant and negative (the trade is a loss). Above the strike, the payoff line is upward sloping as the option payoff rises in proportion with Immunoprecise Antibodies' price. Finally, at the break-even point of 5.8, the line crosses zero, and trading Immunoprecise becomes profitable.
   Profit   
Share
       Immunoprecise Antibodies Price At Expiration  

Immunoprecise short CALL Option Payoff at expiration

By selling Immunoprecise Antibodies' call option, the investors signals his or her bearish sentiment. A short position in a call option written on Immunoprecise Antibodies will generally make money when the underlying price goes down. Therefore Immunoprecise Antibodies' call intrinsic value or payoff at expiration depends on where the Immunoprecise Stock price is relative to the call option strike price. The strike price of 5.0 is the critical point that divides the payoff function into two parts. Below the strike, the payoff chart is constant and positive (the seller makes a profit). Above the strike, the payoff line is downward sloping as the option payoff drops in proportion to Immunoprecise Antibodies' price. Finally, at the break-even point of 5.8, the line crosses zero, and trading Immunoprecise becomes disadvantageous with no downside limits.
   Profit   
Share
       Immunoprecise Antibodies Price At Expiration  
View All Immunoprecise Antibodies Options

Immunoprecise Antibodies Available Call Options

Immunoprecise Antibodies' option chain is a display of a range of information that helps investors for ways to trade options on Immunoprecise. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Immunoprecise. It also shows strike prices and maturity days for a Immunoprecise Antibodies against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Call
2022-10-21 CALL at $2.50.840.050102022-10-210.15 - 4.50.0In
Call
2022-10-21 CALL at $5.00.76250.045712022-10-210.05 - 4.40.15Out

Be your own money manager

Our tools can tell you how much better you can do entering a position in Immunoprecise Antibodies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio File Import Now

   

Portfolio File Import

Quickly import all of your third-party portfolios from your local drive in csv format
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immunoprecise Antibodies using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Risk vs Return Analysis. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.